Synthesis and biological activities of fluorine-substituted (−)-indolactam-V, the core structure of tumor promoter teleocidins

Bioorganic & Medicinal Chemistry Letters
1994.0

Abstract

To investigate the conformation-activity relationship, new indolactam derivatives with a fluorine atom at position 5 or 6 were synthesized. (-)-5-Fluoroindolactam-V (2) existing mainly as the sofa conformer in solution was far less biologically active than (-)-6-fluoroindolactam-V (3) existing mainly as the twist conformer. This suggests that the sofa conformation of (-)-indolactam-V (1) is not a biologically active form. Teleocidins (for example, teleocidin A-l and teleocidin B-4) are potent skin tumor promoters produced by actinomycetes. Teleocidins and their core structure (-)-indolactam-V (1) exist as two stable conformers, a twist and a sofa form, in solution at room temperature. Although recent structure-activity studies using a number of indolactam derivatives have revealed the essential structural factors for tumor-promoting activity, the active conformation of teleocidins remains unclear. To solve this problem, conformationally restricted analogues of teleocidins are indispensable. We have previously reported that 5-substituted indolactam derivatives such as (-)-5-acetyl- and (-)-5-chloroindolactam-V exist exclusively as the sofa conformer. However, the biological activities of these derivatives are expected to reflect both the conformational change and the steric effect at position 5 of the indole ring. To estimate more exactly the activity of the sofa conformer, it is necessary to minimize the steric, electronic, and hydrophobic effects of the substituent at position 5. The most promising candidate is (-)-5-fluoroindolactam-V (2). This communication describes the synthesis and biological activities of (-)-5-fluoroindolactam-V (2) along with those of (-)-6-fluoroindolactam-V (3) as a positive control.

Knowledge Graph

Similar Paper

Synthesis and biological activities of fluorine-substituted (−)-indolactam-V, the core structure of tumor promoter teleocidins
Bioorganic & Medicinal Chemistry Letters 1994.0
Synthesis and biological activities of new conformationally fixed analogues of (−)-indolactam-V, the core structure of tumor-promoting teleocidins
Bioorganic & Medicinal Chemistry Letters 1995.0
Active conformation of a tumor promoter, teleocidin. A molecular dynamics study
Journal of Medicinal Chemistry 1992.0
New Teleocidin-Related Metabolites, (-)-7-Geranylindolactam-V and Blastmycetin F, from Streptoverticillium blastmyceticum
Journal of Natural Products 1994.0
Structure and tumor-promoting activity of new teleocidin-related metabolites (blastmycetins) from Streptoverticillium blastmyceticum.
Agricultural and Biological Chemistry 1988.0
Structure and tumor-promoting activity of new teleocidin-related metabolites (blastmycetins) from Streptoverticillium blastmyceticum.
Agricultural and Biological Chemistry 1988.0
New teleocidin metabolites from Streptoverticillium blastmyceticum.
Agricultural and Biological Chemistry 1985.0
Isolation and biological activities of N13-desmethyl analogues of tumor promoter teleocidin from Streptoverticillium blastmyceticum.
Agricultural and Biological Chemistry 1988.0
Clarification of the Binding Mode of Teleocidin and Benzolactams to the Cys2 Domain of Protein Kinase Cδ by Synthesis of Hydrophobically Modified, Teleocidin-Mimicking Benzolactams and Computational Docking Simulation
Journal of Medicinal Chemistry 1998.0
Isolation of (-)-14-O-Malonylindolactam-V as a Possible Precursor of (-)-Indolactam-V and (-)-14-O-Acetylindolactam-V fromStreptomyces blastmyceticum
Bioscience, Biotechnology, and Biochemistry 1999.0